Creating, updating, saving, and propagating customized views of table and grid information
    1.
    发明授权
    Creating, updating, saving, and propagating customized views of table and grid information 有权
    创建,更新,保存和传播表和网格信息的自定义视图

    公开(公告)号:US09053081B2

    公开(公告)日:2015-06-09

    申请号:US13405172

    申请日:2012-02-24

    IPC分类号: G06F17/00 G06F17/24

    CPC分类号: G06F17/245 G06F17/246

    摘要: Systems, methods, and computer products that create, update, save, and propagate customized views of table and grid information, including spreadsheets. The embodiment of the invention comprises associating at least one column as a first view of the table, associating at least one column as a second view of the table; and combining the first view with the second view, thereby efficiently creating a third view. Further, the combining includes dragging the second view; and dropping the dragged second view into the first view. The combining also includes creating a thumbnail image representing the first view or the second view. It also comprises updating columns that are shared between views. Additionally, the views may be stored, and new views may be propagated from the stored views.

    摘要翻译: 创建,更新,保存和传播表格和网格信息(包括电子表格)的自定义视图的系统,方法和计算机产品。 本发明的实施例包括将至少一列作为表的第一视图,将至少一列相关联,作为该表的第二视图; 以及将第一视图与第二视图组合,从而有效地创建第三视图。 此外,组合包括拖动第二视图; 并将拖动的第二个视图放入第一个视图。 组合还包括创建表示第一视图或第二视图的缩略图。 它还包括更新视图之间共享的列。 此外,可以存储视图,并且可以从存储的视图传播新视图。

    Compositions useful as inhibitors of protein kinases
    2.
    发明授权
    Compositions useful as inhibitors of protein kinases 失效
    可用作蛋白激酶抑制剂的组合物

    公开(公告)号:US08642779B2

    公开(公告)日:2014-02-04

    申请号:US12634136

    申请日:2009-12-09

    摘要: The present invention provides compounds of formula I: or a pharmaceutically acceptable derivative thereof, wherein A, B, Q, R1, and R2 are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of AKT or PDK1 kinase, mammalian protein kinases involved in proliferative and neurodegenerative disorders. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the compounds, and methods of utilizing those compositions in the treatment of various disorders.

    摘要翻译: 本发明提供式I化合物或其药学上可接受的衍生物,其中A,B,Q,R 1和R 2如说明书中所述。 这些化合物是蛋白激酶的抑制剂,特别是AKT或PDK1激酶的抑制剂,涉及增殖和神经变性疾病的哺乳动物蛋白激酶。 本发明还提供包含本发明化合物的药物组合物,制备化合物的方法,以及利用这些组合物治疗各种疾病的方法。

    PYRROLOPYRAZINES AND PYRAZOLOPYRAZINES USEFUL AS INHIBITORS OF PROTEIN KINASES
    4.
    发明申请
    PYRROLOPYRAZINES AND PYRAZOLOPYRAZINES USEFUL AS INHIBITORS OF PROTEIN KINASES 审中-公开
    作为蛋白激酶的抑制剂有用的吡咯并吡嗪和吡唑并吡咯

    公开(公告)号:US20130096302A1

    公开(公告)日:2013-04-18

    申请号:US13650586

    申请日:2012-10-12

    IPC分类号: C07D487/04

    CPC分类号: C07D487/04

    摘要: The present invention relates to compounds useful as inhibitors of Aurora protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.

    摘要翻译: 本发明涉及可用作Aurora蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。